The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

In its Citizen Petition to the FDA, Novo Nordisk argued that there is no clinical need to allow compounding for liraglutide, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

2024 was quite a year for significant strategic action among the pharmaceutical giants. Here are five key trends that will ...

Aiosyn's mitosis detection solution is the first to achieve CE mark under IVDR. It improves efficiency and consistency in ...

A University of Toronto study is providing reassuring evidence about the consumption of soy foods by postmenopausal women.* ...